« Return to News | Drug Sponsors

Boehringer Ingelheim creates biosmiliars division

Tuesday, September 27, 2011 01:36 PM

Boehringer Ingelheim is to tap into the growing interest in biosimilars with the creation of a division dedicated to that market, according to InPharm.

The new venture, which the manufacturer says will be a separate business, is tasked with developing and commercializing Boehringer’s own biosimilars.

“We believe that biosimilars will become a major part of the biopharmaceutical market and will enable many more patients access to important medicines,” explained Wolfram Carius, member of Boehringer’s board of managing directors.

“We feel confident that we are able to leverage our capabilities in product development, supply and clinical expertise at Boehringer Ingelheim to offer high quality biosimilars understanding patients’ needs,” he added.

Biosimilars differ from generics in that they are close copies of, rather than identical to, off-patent biologic brands.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.